XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
6.62
+0.13 (2.00%)
Nov 21, 2024, 4:00 PM EST - Market closed
XBiotech Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 183.12 | 200.02 | 157.31 | 236.98 | 237.37 | 714.59 | Upgrade
|
| Short-Term Investments | - | - | 60.17 | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 183.12 | 200.02 | 217.48 | 236.98 | 237.37 | 714.59 | Upgrade
|
| Cash Growth | -9.43% | -8.03% | -8.23% | -0.16% | -66.78% | 4416.17% | Upgrade
|
| Accounts Receivable | - | - | - | - | 4.11 | - | Upgrade
|
| Other Receivables | 0.87 | 0.94 | 1.76 | 8.95 | 6.57 | - | Upgrade
|
| Receivables | 0.87 | 0.94 | 1.76 | 8.95 | 10.69 | - | Upgrade
|
| Prepaid Expenses | 1.05 | 0.76 | 0.6 | 0.93 | 0.58 | 1.67 | Upgrade
|
| Other Current Assets | - | - | - | - | 77.24 | - | Upgrade
|
| Total Current Assets | 185.03 | 201.72 | 219.84 | 246.87 | 325.88 | 716.26 | Upgrade
|
| Property, Plant & Equipment | 24.82 | 24.9 | 26.26 | 28.31 | 27.34 | 25.17 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | - | 0.53 | 0.44 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | - | 75 | Upgrade
|
| Total Assets | 209.85 | 226.62 | 246.1 | 275.18 | 353.74 | 816.88 | Upgrade
|
| Accounts Payable | 1.51 | 2.52 | 2.41 | 2.07 | 2.49 | 2.15 | Upgrade
|
| Accrued Expenses | 4.49 | 3.5 | 1.6 | 1.37 | 1.35 | 4.18 | Upgrade
|
| Current Income Taxes Payable | - | 0.08 | 0.06 | 0.01 | 0.14 | 49.36 | Upgrade
|
| Current Unearned Revenue | - | - | - | - | - | 4.5 | Upgrade
|
| Total Current Liabilities | 15.99 | 6.1 | 4.07 | 3.45 | 3.98 | 60.19 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 0.06 | 0.87 | - | - | Upgrade
|
| Other Long-Term Liabilities | 1.74 | 1.67 | 1.58 | 1.47 | 1.12 | 1.06 | Upgrade
|
| Total Liabilities | 17.74 | 7.77 | 5.7 | 5.79 | 5.11 | 61.25 | Upgrade
|
| Common Stock | 272.44 | 271.15 | 267.33 | 262.26 | 249.81 | 324.81 | Upgrade
|
| Retained Earnings | -80.33 | -52.31 | -27.75 | 5.15 | 97.57 | 430.93 | Upgrade
|
| Comprehensive Income & Other | - | - | 0.83 | 1.97 | 1.27 | -0.11 | Upgrade
|
| Shareholders' Equity | 192.12 | 218.85 | 240.4 | 269.39 | 348.64 | 755.63 | Upgrade
|
| Total Liabilities & Equity | 209.85 | 226.62 | 246.1 | 275.18 | 353.74 | 816.88 | Upgrade
|
| Net Cash (Debt) | 173.12 | 200.02 | 217.48 | 236.98 | 237.37 | 714.59 | Upgrade
|
| Net Cash Growth | -14.38% | -8.03% | -8.23% | -0.16% | -66.78% | 4416.17% | Upgrade
|
| Net Cash Per Share | 5.68 | 6.57 | 7.14 | 7.89 | 7.70 | 15.43 | Upgrade
|
| Filing Date Shares Outstanding | 30.48 | 30.45 | 30.44 | 30.44 | 29.46 | 28.85 | Upgrade
|
| Total Common Shares Outstanding | 30.48 | 30.44 | 30.44 | 30.44 | 29.3 | 41.52 | Upgrade
|
| Working Capital | 169.04 | 195.62 | 215.78 | 243.42 | 321.89 | 656.07 | Upgrade
|
| Book Value Per Share | 6.30 | 7.19 | 7.90 | 8.85 | 11.90 | 18.20 | Upgrade
|
| Tangible Book Value | 192.12 | 218.85 | 240.4 | 269.39 | 348.64 | 755.63 | Upgrade
|
| Tangible Book Value Per Share | 6.30 | 7.19 | 7.90 | 8.85 | 11.90 | 18.20 | Upgrade
|
| Land | - | 1.42 | 1.42 | 1.42 | 1.42 | 1.42 | Upgrade
|
| Buildings | - | 24.17 | 24.17 | 22.77 | 21.01 | 21.01 | Upgrade
|
| Machinery | - | 16.89 | 16.57 | 17.6 | 15.2 | 13.29 | Upgrade
|
| Construction In Progress | - | 0.47 | 0.4 | 2.06 | 2.63 | 0.19 | Upgrade
|
| Leasehold Improvements | - | - | - | - | - | 0.8 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.